IL-S production by peripheral blood mononuclear cells in nephrotlc patients. We studied the interleukin 8 (IL-8) gene expression by peripheral blood mononuclear cells (PBMC) and the IL-8 serum concentration in patients with idiopathic minimal lesion nephrotic syndrome (IMLNS) and other glomerulopathies. PBMC from eight of the nine (IMLNS) patients in relapse demonstrated the presence of IL-8 mRNA. All three IMLNS patients in remission (P = 0.0026 when compared to patients in relapse) and the two patients with nephrotic syndrome with other glomerulopathies failed to elicit an IL-8 mRNA response. Eleven of the 12 IMLNS patients in relapse showed IL-8 serum concentration above the level of detection. Only one of the seven patients in remission had detectable serum levels of IL-8 (P = 0.0033 when compared to levels from IMLNS patients in relapse). IL-8 serum levels were not detectable in three patients with nephrotic syndrome and other glomerulopathies. Supernatants of PBMC cultures from IMLNS patients in relapse increased the 35sulfate uptake by rat GBM.
uated in vitro. A significant decrease in the percentage of residual 35sulfate incorporated in the GBM (41 5, mean SEM) was observed in cultures treated with IL-8 as compared to those that were not treated with IL-8 (58 8, P < 0.01). Because IL-8 affects the metabolism of GBM compounds that may play a role in glomerular permeability, this lymphokine may have a potential pathogenic role in the proteinuria of IMLNS. Cytokines are hormone-like proteins produced by lymphocytes and monocytes that regulate the function of the immune system. Cytokines are thought to play a role in the pathogenesis of the idiopathic minimal lesion nephrotic syndrome (IMLNS) [1] . Soluble products of peripheral blood mononuclear cells (PBMC) may mediate the increased glomerular permeability to plasma proteins. Circulating factors and supernatants from IMLNS PBMC cultures when injected into the renal artery have been shown to increase glomerular permeability to albumin [2] and to decrease the cationic stains of the capillary wall [3] .
Interleukin 8 (IL-8) is a cytokine originally purified from the supernatant of human monocytes stimulated with lipopolysacReceived for publication November 9, 1992 and in revised form December 21, 1993 Accepted for publication December 23, 1993 © 1994 by the International Society of Nephrology charide [4] but also known to be secreted by lymphocytes, endothelial, and tubular cells. IL-8 was primarily thought to be a neutrophil chemotactic factor. Subsequently, it has been shown to activate neutrophil function and may serve as a secondary mediator of inflammation. Recently, from a variety of recombinant human cytokines tested, we and others have found that IL-8 could alter the metabolism of the rat glomerular basement membrane (GBM) sulfated compounds (unpublished data) [5] . Because this in vitro finding may have pathogenic significance in patients with IMLNS, we measured the plasma concentration of IL-8 and assessed the capability of IL-8 production by PBMC of IMLNS patients at different stages of development of the nephrotic syndrome.
Methods

Patients
Twenty-four patients with IMLNS defined by the International Study of Kidney Disease in Children [6] and four patients with nephrotic syndrome and other glomerulopathies were included in the study. Fifteen were males and thirteen were females. Their ages ranged from three to 20 years with a median age of 10 years.
Patients with ILMNS were studied in remission and in relapse. Remission was defined as serum albumin within normal limits and normal urinary protein excretion (trace or negative by Albustix® or <5 mglm2/hour). Patients were considered in relapse if massive proteinuria (3+ by Albustix or >50 mg/kg! day) and a low serum albumin level (< 25 g/liter) were present.
Detection of circulating interleukin 8
The presence of IL.8 in serum samples of patients with IMLNS and other glomerulopathies was measured by radioimmunoassay using a commercially available kit (R and D Systems Inc., Minneapolis, Minnesota, USA). All samples were studied in duplicate.
Northern blot analysis To detect the presence of mRNA for IL-8, Northern blot analysis was performed on PBMC collected by Ficoll Hypaque density gradient centrifugation of heparinized whole blood [7] from nine patients with IMLNS in relapse, three patients in remission, and two patients with other glomerulopathies (focal segmental glomerulosclerosis and membranous nephropathy) immediately after PBMC cells were collected. In four of the same patients the mRNA expression for IL-8 was also studied after 20 hours of incubation in RPMI 1640 medium.
Total cellular RNA was isolated according to the method of Chomczynski and Sacchi [81. Twenty microgram samples of RNA were fractionated on a 0.8% agarose gel, transferred to Nytran filter paper and then stained with methylene blueacetate to determine presence and integrity of transferred RNA.
Hybridization was performed using a random-primed IL-8 cDNA probe labeled with dCTP-32P [9].
Effect of anti-IL-8 antibody on PBMC mediated increase in 35sulfate uptake by rat glomerular basement membrane
Glomeruli from Sprague-Dawley rats (100 to 350 g) (Charles River, Wilmington, Massachusetts, USA) were isolated by the method described by Fong and Drummond [10] . At the end of the procedure, a drop of the preparation on a glass slide was examined for purity by counting and expressing as a percentage of the total number of glomeruli and nonglomerular fragments. Preparations that were more than 5% contaminated with tubular fragments were discarded.
Glomeruli obtained from each rat were suspended in 6 ml of Basal Medium Eagle (BME, without sulfate, Catalog no: 424-1300, Grand Island Biological Company, New York, New York, USA) and divided into three aliquots. One was cultured with 3 ml of supernatants from PBMC cultures from IMLNS patients in relapse, another was cultured with 3 ml of same supernatant but with the addition of 40 /Lg/ml of anti-human IL-8 neutralizing IgG antibody (Rand D Systems Inc.), and 3 ml of BME was added to the third aliquot. This sample served as the control.
The culture medium was supplemented with 200 mrs glutamine, 100 lU/mi penicillin, 100 j.g/ml streptomycin, 10% decomplemented fetal calf serum, and 80 pCi of 35sulfate (carrier free; New England Nuclear, Boston, Massachusetts, USA). Glomeruli were incubated at 35°C in Petri dishes (50 x 50 mm) in a humidified atmosphere of 5% CO2. Twenty-four hours later, samples were centrifuged, supernatant discarded and pellet lyophilized. The pellet was kept at -70°C until GBM was isolated.
Isolation of the GBM GBM was prepared from lyophilized, isolated glomeruli by the method of Meezan et a! [11] with minor modifications. The washed precipitate was dried and resuspended in Atomlight (New England Nuclear); radioactivity was counted for one minute in a Beckman liquid scintillation counter. Results were expressed in counts per minutes (cpm) per milligram of dry glomerular weight.
Effect of recombinant human monocyte derived IL-8 on 35sulfate uptake by rat GBM Glomeruli obtained from each rat were divided into two aliquots. IL-8 was added to one and the other was cultured alone. Two concentrations (200 and 10.000 pg/mI) were used. Samples, after the addition of 80 pCi 35sulfate, were incubated for 24 hours as previously described. Glomeruli were lyophilized, GBM isolated, and radioactivity counted.
Effect of IL-8 on the 35sulfate turnover of GBM sulfated compounds
Glomeruli obtained from each rat were divided into four aliquots. Glomeruli were incubated in 5 ml of BME supple- At the end of incubation the samples were centrifuged, the supernatants were collected, and the pellet was lyophilized and kept at -35°C until the GBM was isolated. Radioactivity was counted on isolated GBM. Results were expressed in cpm per milligram of dry glomerular weight.
Statistics
Statistical analysis was performed using Fisher exact test, Wilcoxon matched-pairs signed-rank test, Friedman analysis of variance for ranks with the family-wise error maintained at 0.05 with the use of HoIm's stepdown multiple comparison procedure, and 2 x 2 repeated measures analysis of variance.
Results Figure 1 depicts the IL-8 serum concentration in IMLNS patients in relapse and in remission. Eleven of the 12 patients whose IL-8 serum concentration was measured during relapse showed values above the level of detection. Only one of the seven patients studied during remission had a detectable IL-8 serum concentration (P < 0.0033 as compared to relapse patients). This patient went into relapse one week later. All others remained in remission for at least three months after IL-8 was measured. IL-8 serum levels were not detectable in three patients with nephrotic syndrome associated with other glomerulopathies (data not shown).
The expression of the IL-8 gene by PBMC was studied in nine IMLNS patients during relapse, three IMLNS patients during remission, and two patients with other glomerulopathies (focal glomeruloscierosis and membranous nephropathy; Fig. 2A PBMC from IMLNS patients in remission (MIG), in relapse (MG and MFF), and another glomerulopathy (MF) is shown in Figure 3A . Figure 3B shows the methylene blue-acetate stained filter of 20 j.g of total RNA extracted from PBMC of same patients. Figure 3 demonstrates that comparable amounts of total RNA were loaded in each lane. Only the two IMLNS patients in relapse demonstrated the presence of IL-8 mRNA after 20 hours of incubation. The effect of two different concentrations of human monocyte derived IL-8 in 35sulfate incorporation by rat GBM is depicted in Table 1 . At both concentrations, the 35sulfate uptake in rat GBM was significantly higher when glomeruli were cultured with IL-8 than when glomeruli were cultured alone.
The effect of anti-IL-8 neutralizing antibody on supematant PBMC cultures mediated increase 35sulfate uptake in rat GBM is shown in Table 2 . The 35sulfate incorporation in rat GBM was significantly higher when glomeruli were cultured with supernatant from nine IMLNS patients in relapse (800 229 cpmlmg dry glomerular weight; mean SEM) than when glomeruli were cultured with supernatants from the same patients and the addition of anti-IL-8 antibody (400 91 cpm/mg; mean sEM; P = 0.009) or glomeruli were cultured alone (442 94 cpm/mg; mean SEM; P = 0.009). No significant differences in "sulfate uptake were observed when glomeruli alone cultures were compared to glomeruli incubated with supematant from IMLNS patients and the addition of anti-IL-8 antibody (P = 0.48).
The effect of IL-8 on the "sulfate turnover of GBM sulfated compounds is shown in Table 3 . "Sulfate incorporation was significantly higher when glomeruli were cultured with the addition of IL-8 (413 43 cpm/mg dry glomerular weight; mean SEM) than it was when glomeruli were cultured in medium alone (314 39 cpm/mg mean SEM; P < 0.05). Furthermore, the addition of 1 m of MgSO4 to the culture media was associated with a significant decrease in 35sulfate uptake in GBM of both IL-8 treated and medium alone cultures as compared to the uptake observed in cultures without MgSO4 (P <0.0005 and <0.001, respectively), confirming the effect of the chase (nontagged) sulfate molecule in the reincorporation of the radiolabeled sulfate into the GBM sulfated compound. Finally, the percentage of residual "sulfate incorporated in the GBM after 12 hours of incubation with MgSO4 were 41 5 (mean sEM) for cultures stimulated with IL-8 and 58 8 for glomeruli cultured in the absence of IL-8 (P < 0.01), suggesting a higher 35sulfate turnover in the IL-8 treated cultures. Moreover, when the same data were analyzed using F test for interaction in a 2 x 2 repeated measures analysis of variance, once again there was a significant difference between the changes observed after Mg was added to the culture media in both experimental conditions (F = 9.35; P = 0.012). Our data show that IL-8 serum concentrations are increased in IMLNS patients in relapse. All but one of the patients in remission had levels not detectable by the radioimmunoassay. However, one week later this patient was found to have mild edema, proteinuria, and low serum albumin, indicating that the increased IL-8 serum concentration had preceded the development of proteinuria. Furthermore, the elevated serum levels seem to be restricted to IMLNS patients since the three patients with proteinuria associated with other glomerulopathies had undetectable serum levels of IL-8.
IL-S is secreted by monocytes or lymphocytes [121 and other nonimmune types of human cells. These include proximal and distal tubular [13] and endothelial cells [14] . In this study, we present evidence that PBMC from IMLNS patients in relapse can express and secrete IL-8. This increase release of IL-8 by PBMC could cause, at least in part, the elevated IL-S serum levels observed in these patients.
The reason for the spontaneous increase in IL-8 production by PBMC in these patients is not known. It does not seem to be secondary to the nephrotic state, since patients with other types of nephrotic syndrome did not have detectable IL-8 in their serum. Most nephrotic patients' relapses are preceded by a respiratory tract infection [151. This perhaps triggers the gene expression for IL-S. However, this hypothesis cannot be confirmed because no data are available on the effect of viral infections on PBMC IL-8 production.
An unexpected finding in this study was the presence of mRNA for IL-8 after PBMC from IMLNS patients in relapse were incubated for 20 hours. In the original studies on IL-8 Table 2 . Effect of anti-IL-8 neutralizing antibody on PBMC mediated increased "sulfate uptake by rat GBM X,2 = 13.8; P < 0.01.
A vs. B, P = 0.009; A vs. C, P = 0.009; B vs. C, P = 0.48. secretion, when normal monocytes were stimulated with LPS, the mRNA IL-8 production was shut down after a few hours despite persistence of the stimulus in the culture media [4] . In our patients, the gene associated with the increased production of mRNA for IL-8 did not down-regulate after 20 hours in culture, despite the absence of a known stimulus for IL-8 secretion of IL-8 and its increased serum concentration.
There are scarce data on serum concentration of lymphokines in patients with nephrotic syndrome. In a group of patients with IMLNS, membranoproliferative glomerulopathy and diabetic nephropathy, Suranyi et al found that only tumor necrosis factor (TNF) plasma concentrations were elevated with respect to normal controls. Plasma levels of IL-i, IL-2 and interferons (IFN A and B) were not different than those observed in normal Schnaper has determined that urine and serum from certain nephrotic patients contain a suppressor lymphokine (soluble immune response suppressor, SIRS) that inhibits antibody production and delayed type hypersensitivity response in vivo [17] . SIRS is produced by lymphocytes from patients with IMLNS and other glomerulopathies, and also by patients with other diseases who are not nephrotic. Furthermore, there is no evidence to support a role for SIRS in mediating proteinuria in nephrotic syndrome [17] .
IL-2, IL-4 and SIRS are lymphokines found in the supernatant of PBMC cultures from patients with IMLNS and other glomerulopathies [18] [19] [20] . Their role in the development of proteinuna in IMLNS is unknown. Because all these lymphokines have been detected in patients with nephrotic syndrome other than IMLNS, it is currently thought that they play a secondary role, if any, in the increased glomerular permeability to plasma proteins. Moreover, the significance of these in vitro findings is questionable because, as in the case of IL-2, PBMC from nephrotic patients have been shown to release IL-2 in the culture media [20] but no increase in serum IL-8 concentration has been reported [16] .
Previous studies have hypothesized a role for lymphokines in the proteinuria of IMLNS. In this report, we have shown that PBMC from IMLNS patients in relapse express IL-8 mRNA and that only IMLNS patients in relapse had an increased IL-8 serum concentration.
Furthermore, it seems that the previously described [21] in vitro effect of the PBMC supernatants from IMLNS patients in relapse is mediated, at least in part, by IL-8 because: (a) IL-8 was detected in the supernatants of the PBMC cultures from these patients (data not shown); (b) this effect was abolished by the addition of anti-IL-8 neutralizing antibody to the culture media; and (c) the addition of IL-8 to the culture media in concentrations found in the serum of IMLNS patient in relapse also increased the 35sulfate uptake by the GBM.
IL-8 found in the serum of the IMLNS patients in relapse may play a role in the metabolism of glomerular sulfated compounds since some IL-8 concentrations observed in the serum of these patients were found in vitro to increase the 35sulfate uptake by rat GBM.
Finally, our in vitro experiments demonstrate that the augmented GBM 35sulfate incorporation associated with IL-8 or the supernatants from IMLNS PBMC cultures [22] is secondary to an increased 35sulfate turnover of the GBM sulfated compounds.
Polyanionic molecules in the GBM have been demonstrated to restrict the passage of anionic serum proteins to the urinary space by creating a charge selective barrier. This barrier seems to play a major role in the glomerular permeability to serum albumin in IMLNS. The nature of this electrostatic screen has not been defined. Sulfate from heparan sulfate proteoglycan and carboxylic groups from other molecules in the GBM might be the key components. Although our results do not prove IL-8 to be the pathogenetic lymphokine in IMLNS, these studies demonstrating its presence in the serum of patients during relapse and its effect on sulfate turnover in the glomerular basement membrane, albeit indirect, suggest a possible relationship between IL-8 and increased glomerular permeability to proteins. Further studies including the chronic infusion of in the renal artery of experimental animals are required to evaluate the potential of IL-8 as a proteinuria inducing lymphokine in IMLNS.
